Innovation Pharmaceuticals Inc (IPIX)

[frrol]

That lie about his academic credentials is troubling though, I wish he would address it (clear it up or remove it). Lies hurt credibility. If Kevetrin results are positive, the issue will become less relevant of course. Until then though, his word is not good. And he gives fodder for legitimate criticism that affects our stock price and cost of capital. I'm going to write the company and ask, unless someone has already got a response from them on this matter?